StonvexLoading…
StonvexStonvexStonvexCore line items from GEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.63B | $1.66B | $1.72B | $2.79B |
Operating Income | $258.19M | $169.96M | $205.13M | $315.01M |
Net Income | $-440.40M | $-63.95M | $117.72M | $75.46M |
EPS (Diluted) | $-4.19 | $-1.24 | $0.22 | $-0.04 |
Total Assets | $4.86B | $7.04B | $7.02B | $6.37B |
Total Liabilities | $4.15B | $5.52B | $5.31B | $4.59B |
Cash & Equivalents | $6.44M | $7.35M | $9.23M | $7.93M |
Free Cash Flow OCF − CapEx | $65.94M | $-195.21M | $-98.89M | $-89.80M |
Shares Outstanding | 122.46M | 122.46M | 122.53M | 122.58M |